![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
Revisiting
the IOM Report (GoozNews)
In his blog, Merrill Goozner discusses an editorial in the Oct. 26 issue of
the New England Journal of Medicine that asks Congress "to take
prompt action to enact the more far-reaching elements" of the Institute
of Medicine (IOM) report on drug safety released last month. These elements
include "critical issues of financing, transparency and independence,"
he writes, quoting the editorial.
He also discusses another issue mentioned in the report that he finds particularly important, which is that FDA advisory committees comprise many members with industry ties. "The IOM report called for a 'substantial majority' of those advisers to have no ties to firms the agency regulates," he writes. "If the new Congress takes FDA reform seriously, ending conflicts of interests on the FDA's advisory committees will rank high on its agenda."
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct